New cancer clinical trial: Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer

Published on: January 29, 2018 at 12:00PM
Condition:   Colorectal Neoplasms
Interventions:   Drug: Apatinib;   Drug: standard second-line chemotherapy
Sponsor:   Liqiang Zhong
Not yet recruiting
http://ift.tt/2nmhYiW